Spacer
GVK Bio GVK Bio Company Home Business Development News Services Literature Careers Contact bioCampus  
Spacer Spacer
Spacer
Printable
GVK Bio Informatics
Spacer
GVK Bio Chemistry
Spacer
GVK Bio Clinical Pharmacology
Spacer
GVK Bio Process R&D
Spacer
GVK Bio Clinical Research
Spacer
GVK Bio Biology
Spacer
  Clinical Research
Spacer
 
Services

Post Marketing Pharmacovigilance
  1. 24x7 Customer Call receipt & Triage
    • Call receipt 24X7
    • Call triage
    • Call routing to appropriate stakeholder
    • Call information capture in database
    • Call management
    • Forward integration with case processing services

  2. ADR/ADE case processing & reporting
    • Data entry into validated electronic database including historic safety data
    • Quality control
    • Medical review, narrative writing, MedDRA coding
    • Reporting: Electronic (E2B), Hard copy (CIOMS, MedWatch 3500A drug, etc.)

  3. Periodic ADR/ADE Reporting (PSURs/PADERs)
    • Complete PSUR/PADER generation
    • Formats: ICH E2C, Volume 9a, US FDA 21 CFR Part 314.80, Schedule Y
    • Literature searches
    • Generation of case narrative

  4. Product Quality Complaints (PQC) Management
    • Call receipt 24X7
    • Management of complete cycle from receipt of complaints to response to complainants
    • Complaint processing into database
    • Complaint distribution to Quality Assurance locations and follow up for analysis report
    • PQC reconciliation
    • Medical analysis of complaints

  5. Medical Inquiries Management
    • Call receipt 24X7
    • Management of standard and off label customer inquiries
    • Management of complete cycle from receipt of inquiries to response
    • Capture of inquiries in database

  6. Electronic Safety Database Validation
    • Validation plan preparation
    • End to end validation activities
    • Post ‘Go live’ support

  7. Safety Data Exchange Agreement Management
    • Drafting SDEAs customized per global regulatory requirements
    • Review of SDEAs
    • Exchange of ADRs with business partners after execution of SDEA

  8. Signal Detection- Benefit Risk Evaluation
    • Causality and Medical assessment, statistical analysis

  9. Risk Management Plans/Programs
    • Writing Risk Management Plans as defined in the Template for EU RMP (Doc.Ref. EMEA/192632/2006)

  10. Literature monitoring for ADR/ADE
    • Ongoing, weekly literature monitoring for identification of ICSRs (Individual Case Safety Reports)
    • Active ingredient specific – alternative names/ Product specific
    • Integration with case processing in safety database
    • Full text articles procurement

  11. Training of company employees on ADR/ADE reporting
    • Pharmacovigilance specific trainings for pharmacovigilance department
    • Training on pharmacovigilance for company employees including medical representatives

  12. Global Compliance monitoring and audits
    • Review of company’s compliance data on monthly basis
    • Pharmacovigilance audits and recommendations

  13. Inspections Management
    • Support for management of inspections by global regulatory authorities
    • Support for CAPA execution for closure of inspection findings

  14. Department restructuring, turnkey operation
    • SOP development
    • Recommendations for pharmacovigilance department designing and development
    • Recommendations for improvements in the existing pharmacovigilance systems

    Pre-authorization (Clinical Trial) Pharmacovigilance
  15. End to end SAE management services
    • 24 x 7 Call receipt & Triage
    • Processing of SAEs & electronic reporting
    • Causality assessment
    • Annual Safety Reports
    • Clinical Trials Safety Data Management
 
   
  top
   
 
   
Spacer Spacer
GVK Bio Clinical Operations
GVK Bio Pharmacovigilance
GVK Bio Medical Writing
GVK Bio Medical Affairs
GVK Bio Clinical Data Management
GVK Bio Biostatistics
GVK Bio Therapeutic Focus
GVK Bio Write to us
   
GVK Bio Pharmacovigilance
Spacer Spacer
  Aims and Objectives
  Services
  GVK BIO Advantage